Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients
Sungyong You(Cedars-Sinai Medical Center), Stephen B. Williams(Cedars-Sinai Medical Center), Eduardo Eyzaguirre(The University of Texas Medical Branch at Galveston), Dan Theodorescu(University of Arizona), Alexander Yu(The University of Texas Medical Branch at Galveston), Amanda M. De Hoedt(Durham VA Health Care System), Keith Syson Chan(Cedars-Sinai Medical Center), Stephen J. Freedland(Cedars-Sinai Medical Center), Woonyoung Choi(Johns Hopkins University), Lars Dyrskjøt(Aarhus University Hospital), Yunhee Choi-Kuaea(Cedars-Sinai Medical Center), Gloria C. Galván(Cedars-Sinai Medical Center), David J. McConkey(Johns Hopkins University), Minhyung Kim(Cedars-Sinai Medical Center), Steven G. Widen(The University of Texas Medical Branch at Galveston), Yong Shan(The University of Texas Medical Branch at Galveston), Douglas S. Tyler(University of North Carolina at Chapel Hill)
Cited by 15
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
A Consensus Molecular Classification of Muscle-invasive Bladder Cancer
|European Urology|2019|1.4k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k